Alle verbonden artikelen

Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer.

Auteurs : Saini KS, Loi S, de Azambuja E, Metzger-Filho O, Saini ML, Ignatiadis M, Dancey JE, Piccart-Gebhart M
Jaar : 2013
Journal : Cancer Treat Rev
Volume : 39(8)
Pagina's : 935-46

High-risk human papillomavirus infection in HIV-positive African women living in Europe.

Auteurs : Konopnicki D, Manigart Y, Gilles C, Barlow P, De Marchin J, Feoli F, Larsimont D, Delforge M, De Wit S, Clumeck N
Jaar : 2013
Journal : J Int AIDS Soc
Volume : 16
Pagina's : 18023

Circulating tumor cells and response to neoadjuvant paclitaxel and HER2-targeted therapy: A sub-study from the NeoALTTO phase III trial.

Auteurs : Azim HA, Rothé F, Aura CM, Bavington M, Maetens M, Rouas G, Gebhart G, Gamez C, Eidtmann H, Baselga J, Piccart-Gebhart M, Ellis C, Vuylsteke P, Cure H, Domont J, Ferro A, Toral-Peña JC, de Azambuja E, Sotiriou C, Di Cosimo S, Ignatiadis M
Jaar : 2013
Journal : Breast
Volume : 22(6)
Pagina's : 1060-5

Safety and efficacy of everolimus with exemestane vs. exemestane alone in elderly patients with HER2-negative, hormone receptor-positive breast cancer in BOLERO-2.

Auteurs : Pritchard KI, Burris HA, Ito Y, Rugo HS, Dakhil S, Hortobagyi GN, Campone M, Csöszi T, Baselga J, Puttawibul P, Piccart-Gebhart M, Heng D, Noguchi S, Srimuninnimit V, Bourgeois H, Gonzalez Martin A, Osborne K, Panneerselvam A, Taran T, Sahmoud T, Gnant M
Jaar : 2013
Journal : Clin Breast Cancer
Volume : 13(6)
Pagina's : 421-432.e8

5-aza-2'-deoxycytidine has minor effects on differentiation in human thyroid cancer cell lines but modulates genes that are involved in adaptation in vitro.

Auteurs : Dom G, Chico Galdo V, Tarabichi M, Tomás G, Hébrant A, Andry G, De Martelaer V, Libert F, Leteurtre E, Dumont JE, Maenhaut C, van Staveren W
Jaar : 2013
Journal : Thyroid
Volume : 23(3))
Pagina's : 317-28

The European lung corner.

Auteurs : Sculier JP
Jaar : 2013
Journal : Eur. Respir. J.
Volume : 42(6)
Pagina's : 1433-4

Targeting RANKL in breast cancer: bone metastasis and beyond.

Auteurs : Azim H, Azim HA
Jaar : 2013
Journal : Expert Rev Anticancer Ther
Volume : 13(2)
Pagina's : 195-201

Ibrutinib : a major breakthrough in the treatment of CLL and other lymphoproliferative disorders.

Auteurs : Bron D
Jaar : 2013
Journal : Belgian J Hematology
Volume : 4(3)
Pagina's : 102-105

Desire for formal psychological support among caregivers of patients with cancer: prevalence and implications for screening their needs. (epub online 2012)

Auteurs : Merckaert I, Libert Y, Lieutenant F, Moucheux A, Farvacques C, Slachmuylder JL, Razavi D
Jaar : 2013
Journal : Psychooncology
Volume : 22(6)
Pagina's : 1389-95

Magnitude of Trastuzumab Benefit in Patients With HER2-Positive, Invasive Lobular Breast Carcinoma: Results From the HERA Trial.

Auteurs : Metzger-Filho O, Procter M, de Azambuja E, Leyland-Jones B, Gelber Rd, Dowsett M, Loi S, Saini KS, Cameron D, Untch M, Smith I, Gianni L, Baselga J, Jackisch C, Bell R, Sotiriou C, Viale G, Piccart-Gebhart M
Jaar : 2013
Journal : J. Clin. Oncol.
Volume : 31(16)
Pagina's : 1954-60

Analysis of Regional Timelines To Set Up a Global Phase III Clinical Trial in Breast Cancer: The Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Experience.

Auteurs : Metzger-Filho O, de Azambuja E, Bradbury I, Saini KS, Bines J, Simon SD, Dooren VV, Aktan G, Pritchard KI, Wolff AC, Smith I, Jackisch C, Lang I, Untch M, Boyle F, Xu B, Baselga J, Perez EA, Piccart-Gebhart M
Jaar : 2013
Journal : Oncologist
Volume : 18(2)
Pagina's : 134-40

A Randomized Study of Interferon a-2b Versus No Treatment as Consolidation After High Dose Therapy and Autologous Stem Cell Transplantation for Patients With Relapsed Lymphoma.

Auteurs : Bosly A, Grigg A, Holte H, Gisselbrecht C, Radford J, Rossi A, Lopez-Guillermo A, Trneny M, Sebban C, Hagberg H, Leal da Costa F, Colombat P, Bron D, Coiffier B
Jaar : 2013
Journal : Oncologist
Volume : 18(11)
Pagina's : 1189

Effect of age on breast cancer outcomes in women with human epidermal growth factor receptor 2-positive breast cancer: results from a herceptin adjuvant trial.

Auteurs : Partridge AH, Gelber S, Piccart-Gebhart M, Focant F, Scullion M, Holmes E, Winer EP, Gelber Rd
Jaar : 2013
Journal : J. Clin. Oncol.
Volume : 31(21)
Pagina's : 2692-8

Radioembolization of the Spleen: A Revisited Approach for the Treatment of Malignant Lymphomatous Splenomegaly. (epub online 2012)

Auteurs : Muylle K, Nguyen J, de Wind A, Meuleman N, Delatte P, Vanderlinden B, Roelandts M, Vanderstappen A, Bron D, Flamen P
Jaar : 2013
Journal : Cardiovasc Intervent Radiol
Volume : 36(4)
Pagina's : 1155-60

Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: a randomised, controlled, phase 3 trial.

Auteurs : Goss PE, Smith IE, + collaborators (among others :, Piccart-Gebhart M, Finkelstein DM
Jaar : 2013
Journal : Lancet Oncol
Volume : 14(1)
Pagina's : 88-96

Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement.

Auteurs : Azim HA, Michiels S, Zagouri F, Delaloge S, Filipits M, Namer M, Neven P, Symmans WF, Thompson A, André F, Loi S, Swanton C
Jaar : 2013
Journal : Ann Oncol
Volume : 24(3)
Pagina's : 647-54

Evidences of early senescence in multiple myeloma bone marrow mesenchymal stromal cells.

Auteurs : André T, Meuleman N, Stamatopoulos B, De Bruyn C, Pieters K, Bron D, Lagneaux L
Jaar : 2013
Journal : PLoS One
Volume : 8(3)
Pagina's : e59756

Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98.

Auteurs : Loi S, Sirtaine N, Piette F, Salgado R, Viale G, Van Eenoo F, Rouas G, Francis P, Crown JP, Hitre E, de Azambuja E, Quinaux E, Di Leo A, Michiels S, Piccart-Gebhart M, Sotiriou C
Jaar : 2013
Journal : J. Clin. Oncol.
Volume : 31(7)
Pagina's : 860-7

Rational approach of leucocytosis in adults].

Auteurs : Bron D
Jaar : 2013
Journal : Rev Med Brux
Volume : 34(4)
Pagina's : 339-42

Stratified medicine: a call for action.

Auteurs : Jacob I, Awada A, Payne K, Annemans L
Jaar : 2013
Journal : Expert Rev Pharmacoecon Outcomes Res
Volume : 13(3)
Pagina's : 277-9